At the time of writing, Establishment Labs Holdings Inc [ESTA] stock is trading at $39.69, up 0.05%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ESTA shares have gain 5.56% over the last week, with a monthly amount glided 10.56%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 23, February 2024, Establishment Labs Announces Participation in Two Upcoming Investment Conferences. In a post published today on Yahoo Finance, Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in two upcoming investment conferences.
From an analyst’s perspective:
Establishment Labs Holdings Inc [NASDAQ: ESTA] stock has seen the most recent analyst activity on August 31, 2023, when JP Morgan initiated its Overweight rating and assigned the stock a price target of $75. Previously, Citigroup started tracking the stock with Buy rating on June 29, 2023, and set its price target to $79. Mizuho started tracking the stock assigning a Buy rating and suggested a price target of $70 on October 13, 2022. B. Riley Securities initiated its recommendation with a Buy and recommended $107 as its price target on August 24, 2022. UBS started tracking with a Buy rating for this stock on August 27, 2020, and assigned it a price target of $23. In a note dated May 14, 2020, Goldman initiated an Neutral rating and provided a target price of $20 on this stock.
For the past year, the stock price of Establishment Labs Holdings Inc fluctuated between $16.96 and $79.88. Currently, Wall Street analysts expect the stock to reach $98.5 within the next 12 months. Establishment Labs Holdings Inc [NASDAQ: ESTA] shares were valued at $39.69 at the most recent close of the market. An investor can expect a potential return of 148.17% based on the average ESTA price forecast.
Analyzing the ESTA fundamentals
According to Establishment Labs Holdings Inc [NASDAQ:ESTA], the company’s sales were 177.40M for trailing twelve months, which represents an 0.68% jump. Gross Profit Margin for this corporation currently stands at -0.03% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.24%, and Net Profit Margin reading is -0.51%. To continue investigating profitability, this company’s Return on Assets is posted at -1.53, Equity is -2.61 and Total Capital is -22.65. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 38.75 points at the first support level, and at 37.80 for the second support level. However, for the 1st resistance point, the stock is sitting at 40.46, and for the 2nd resistance point, it is at 41.22.
Establishment Labs Holdings Inc [ESTA] reported earnings per share of -$1.12 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.8/share, meaning a difference of -$0.32 and a surprise factor of -40.00%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.65 per share as compared to estimates of -$0.72 per share, a difference of $0.07 representing a surprise of 9.70%.
Ratios To Look Out For
It is important to note that Establishment Labs Holdings Inc [NASDAQ:ESTA] has a current ratio of 3.71. In addition, the Quick Ratio stands at 2.33 and the Cash Ratio stands at 0.05. Considering the valuation of this stock, the price to sales ratio is 5.77, the price to book ratio is 33.60.
Transactions by insiders
Recent insider trading involved LEWIN NICHOLAS SHERIDAN, Director, that happened on Dec 14 when 2000.0 shares were purchased. Director, LEWIN NICHOLAS SHERIDAN completed a deal on Nov 20 to buy 5000.0 shares. Meanwhile, Chief Financial Officer Denhoy Raj bought 2250.0 shares on Nov 17.
